Read our new case study to discover how market research helped a client understand how to bring a new cancer treatment into the market
The study was conducted with a clinical-stage biotechnology company that focuses on the development of therapeutic antibodies for improvement in cancer treatment. The aim was to understand the data that clinical trials need to demonstrate in order to bring the treatment into the market. The research was carried out across the USA and five key European Markets.
Research into rare diseases such as CTCL can prove challenging. Below you can learn how our global team of experts helped design, recruit and interview M3 Global Research panellists to deliver a successful result.
Not a Member of our Panel Yet?
Not a member of our panel yet?
Recommended related articles:
The latest market research case study we conducted is about rare disease treatments in oncology with the aim to improve patient outcomes. Read more.
Market research case study on rare disease treatments in oncology
In this case study, one of the biggest healthcare organizations, the UK’s National Health Service (NHS) worked with the M3 panel to run a series of co-creation workshops. . Read more.
How market research has helped NHS patient engagement